Once weekly insulin: Reinventing the insulin experience

Novo Nordisk A/S |
Thursday

Chair: Tina Vilsbøll (DNK) 14:15 – 14:19 Welcome and introductions Tina Vilsbøll (DNK) 14:19 – 14:28 First phase 3 evidence for a once-weekly insulin Athena Philis-Tsimikas (USA)Stephen Bain (UK) 14:28 – 14:45 Advancing diabetes management with once-weekly insulin Panel discussion and Q&A All faculty 22.09.2022 14:15 – 14:45 Networking Hub